StonvexLoading…
StonvexStonvexStonvexCore line items from NXL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.95K | $301.65K | $129.75K | $111.60K |
Operating Income | $-2.12M | $-8.39M | $-5.98M | $-3.63M |
Net Income | $-2.10M | $-8.22M | $-5.85M | $-3.57M |
EPS (Diluted) | $-0.11 | $-0.50 | $-0.37 | $-0.25 |
Total Assets | $3.69M | $4.64M | $5.13M | $6.56M |
Total Liabilities | $808.36K | $887.33K | $357.52K | $600.58K |
Cash & Equivalents | $1.21M | $654.78K | $590.08K | $431.32K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 20.58M | 19.19M | 18.19M | 17.42M |